Table of Contents Table of Contents
Previous Page  90 / 92 Next Page
Information
Show Menu
Previous Page 90 / 92 Next Page
Page Background

88

NCCN Guidelines for Patients

®

Stomach Cancer, Version 1.2016

Index

Index

2

nd

opinion

76

biopsy

21, 23–24, 26

cancer staging

12–18

chemoradiation

21, 24, 37, 50–51, 54–59, 68

chemotherapy

20, 37, 40–44, 46, 51, 54–59, 63, 65–68

clinical trial

45, 62–63, 73

complementary and alternative medicine

42

complete blood count

21–22

comprehensive chemistry profile

21–22, 55

computed tomography

21, 24, 37, 52–53, 55, 60–61

endoscopic treatment

32–34, 66–68

gastrectomy

35–36, 46, 51

HER2

21, 27, 43–44, 65

hereditary diffuse stomach cancer

22

lymph node dissection

36, 51

medical history

20–22, 52–53, 60–61

NCCN Member Institutions

87

NCCN Panel Members

86

nutrition

20, 28, 30, 36

pathology report

72, 76

performance status

62–63, 65

physical exam

21–22, 52, 60

positron emission tomography

21, 25, 55

radiation therapy

37–38, 46,66

shared decision-making

71, 78

supportive care

28, 34, 50–51, 53–59, 61–63, 68

targeted therapy

41, 43–44, 46, 65

upper GI endoscopy

21, 25, 52–53, 60–61

VEGF

43